Collage of multiple pictures with two men, a building solar installation and a Pride Alliance eventSustainability Banner
We're continuing to successfully deliver against our ESG commitments, with examples including:
  • Supporting comprehensive and diverse clinical trials investigating a twice-yearly injectable for HIV prevention.
  • Centering access and removing barriers to care: Our voluntary licensing programs provided access to 14.8 million HIV & HBV treatments and 8.3 million remdesivir-based treatments for COVID-19 in 2024. We also donated over $300 million in 2024 to global programs and partners aligned with our mission,
  • Continuing to innovate for unmet needs including a therapy made available in 2024 for primary biliary cholangitis (PBC), a rare liver disease.
  • Making significant progress toward ambitious energy reduction targets: surpassing our 2024 energy reduction KPI by 1.1 million kWh and realizing $1.8M in total energy cost savings/avoidance

Impact by the Numbers

14.8M

HIV and HBV treatments made available in 2024

781K

Healthcare providers educated through Gilead’s independent medical education program

271K

People reached with direct HIV services through RADIAN partnership in Eastern Europe and Central Asia since 2019

20M+

HIV and viral hepatitis tests conducted through Gilead’s FOCUS program since 2010

11.7K

Employee volunteer hours in 2024

$300M

Donated globally in 2024

Data updated annually. Next update scheduled for April 2026.

External Ratings and Rankings

ESG-Performance-Hand-Leaf ESG-Performance-Hand-Leaf
We were included on the Dow Jones Sustainability World Index as one of the most sustainable pharmaceutical companies for the fourth consecutive year in 2024.
ESG-Performance-Group-Members ESG-Performance-Group-Members
in 2025, Gilead was once again ranked in the top five of America's Most Just Companies in biopharma, reflecting our commitment to operating responsibly.
ESG-Performance-Hand-Equity ESG-Performance-Hand-Equity
We've received a perfect score of 100 on the Human Rights Campaign Corporate Equality Index since 2018.

ESG Awards

Environmental

ESG-Performance-Environmental

CDP Leader

Scored A- in Climate Change and B- in Water Security questionnaires for environmental disclosure non-profit

Green Buildings

Earned one WELL and five LEED certifications

Social

ESG-Performance-Social

Highly Ranked

Ranked Best at ESG According to 2024 PatientView survey of 700+ patient advocacy groups

Innovation

Most Innovative Recognition by Fast Company for Gilead's COMPASS Initiative®

Governance

ESG-Performance-Governance

Political Transparency

Ranked in top tier of pharma companies on Zicklin Political Accountability Scorecard

Board of Directors

Recognized by the National Association of Corporate Directors Center for Inclusive Governance